Ascendiant Capital Markets Lowers Sintx Technologies (NASDAQ:SINT) Price Target to $12.00

Sintx Technologies (NASDAQ:SINT) had its price objective decreased by investment analysts at Ascendiant Capital Markets from $16.00 to $12.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Ascendiant Capital Markets’ price objective indicates a potential upside of 351.13% from the company’s current price.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $12.00.

Sintx Technologies Stock Performance

NASDAQ:SINT opened at $2.66 on Wednesday. The company has a market cap of $10.96 million, a PE ratio of -0.47 and a beta of 0.66. Sintx Technologies has a 52-week low of $1.71 and a 52-week high of $6.78. The stock has a 50-day simple moving average of $2.82 and a 200 day simple moving average of $3.42.

Institutional Trading of Sintx Technologies

A number of hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC lifted its position in shares of Sintx Technologies by 33.5% in the second quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock valued at $49,000 after buying an additional 3,848 shares during the last quarter. Veracity Capital LLC lifted its holdings in Sintx Technologies by 10.3% during the 3rd quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock worth $327,000 after purchasing an additional 7,464 shares during the last quarter. Finally, Virtus Wealth Solutions LLC acquired a new stake in Sintx Technologies during the 3rd quarter worth approximately $388,000. 18.38% of the stock is owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.